These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 2829215)
1. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Heck MM; Hittelman WN; Earnshaw WC Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1086-90. PubMed ID: 2829215 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung. Giaccone G; van Ark-Otte J; Scagliotti G; Capranico G; van der Valk P; Rubio G; Dalesio O; Lopez R; Zunino F; Walboomers J Biochim Biophys Acta; 1995 Dec; 1264(3):337-46. PubMed ID: 8547322 [TBL] [Abstract][Full Text] [Related]
3. Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Woessner RD; Mattern MR; Mirabelli CK; Johnson RK; Drake FH Cell Growth Differ; 1991 Apr; 2(4):209-14. PubMed ID: 1651102 [TBL] [Abstract][Full Text] [Related]
4. Higher expression of topoisomerase II in lung cancers than normal lung tissues: different expression pattern from topoisomerase I. Hasegawa T; Isobe K; Nakashima I; Shimokata K Biochem Biophys Res Commun; 1993 Aug; 195(1):409-14. PubMed ID: 8395833 [TBL] [Abstract][Full Text] [Related]
5. DNA topoisomerase I and II activities during cell proliferation and the cell cycle in cultured mouse embryo fibroblast (C3H 10T1/2) cells. Tricoli JV; Sahai BM; McCormick PJ; Jarlinski SJ; Bertram JS; Kowalski D Exp Cell Res; 1985 May; 158(1):1-14. PubMed ID: 2987005 [TBL] [Abstract][Full Text] [Related]
6. Gene expression of DNA topoisomerases I, II alpha and II beta and response to cisplatin-based chemotherapy in advanced ovarian carcinoma. Cornarotti M; Capranico G; Bohm S; Oriana S; Spatti GB; Mariani L; Ballabio G; Zunino F Int J Cancer; 1996 Aug; 67(4):479-84. PubMed ID: 8759604 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 induces the activities of DNA topoisomerase I and DNA topoisomerase II in HuT 78 cells. Pham MH; Kondapalli N; Reckord CL; Foglesong PD Biochem Biophys Res Commun; 2009 Dec; 390(3):577-80. PubMed ID: 19818738 [TBL] [Abstract][Full Text] [Related]
8. [Poisons of DNA topoisomerases I and II]. Charcosset JY; Soues S; Laval F Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034 [TBL] [Abstract][Full Text] [Related]
9. Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II. Lee JH; Berger JM Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31671531 [TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells. Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205 [TBL] [Abstract][Full Text] [Related]
11. Studies on DNA topoisomerases I and II in herpes simplex virus type 2-infected cells. Bapat AR; Han FS; Liu ZC; Zhou BS; Cheng YC J Gen Virol; 1987 Aug; 68 ( Pt 8)():2231-7. PubMed ID: 3039049 [TBL] [Abstract][Full Text] [Related]
12. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Jacob S; Aguado M; Fallik D; Praz F Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654 [TBL] [Abstract][Full Text] [Related]
13. Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Hsiang YH; Wu HY; Liu LF Cancer Res; 1988 Jun; 48(11):3230-5. PubMed ID: 2835157 [TBL] [Abstract][Full Text] [Related]
14. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex. Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981 [TBL] [Abstract][Full Text] [Related]
15. Topoisomerase II: A specific marker for cell proliferation. Heck MM; Earnshaw WC J Cell Biol; 1986 Dec; 103(6 Pt 2):2569-81. PubMed ID: 3025219 [TBL] [Abstract][Full Text] [Related]
17. Monitoring the DNA Topoisomerase II Checkpoint in Saccharomyces cerevisiae. Furniss K; Vas ACJ; Lane AB; Clarke DJ Methods Mol Biol; 2018; 1703():217-240. PubMed ID: 29177745 [TBL] [Abstract][Full Text] [Related]
18. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines. Goldwasser F; Bae I; Fornace AJ; Pommier Y Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795 [TBL] [Abstract][Full Text] [Related]
19. The activity of topoisomerases is related to the grade and stage in human renal cell carcinoma. Shuin T; Sano K Anticancer Res; 1994; 14(6B):2621-6. PubMed ID: 7872691 [TBL] [Abstract][Full Text] [Related]
20. Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II. Burden DA; Goldsmith LJ; Sullivan DM Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):297-304. PubMed ID: 8392338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]